Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis

TA Kirschberg, M Balakrishnan, W Huang…

文献索引：Kirschberg, Thorsten A.; Balakrishnan, Mini; Huang, Wei; Hluhanich, Rebecca; Kutty, Nilima; Liclican, Albert C.; McColl, Damian J.; Squires, Neil H.; Lansdon, Eric B. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 3 p. 1131 - 1134

全文：HTML全文

被引用次数: 28

摘要

Despite their longstanding use in the context of highly active anti-retroviral therapy (HAART) for the treatment of HIV infections, non-nucleoside reverse-transcriptase inhibitors (NNRTIs) continue to be the focus of much pharmaceutical research. 1 Three NNRTIs are currently approved for clinical use: Efavirenz, Nevirapine, and Delavirdine (Fig. 1). Other compounds, such as TMC-125 and TMC-278, have entered late stage clinical trials. 2 Mode of action studies ...